Michelle McMullen

924 total citations
16 papers, 674 citations indexed

About

Michelle McMullen is a scholar working on Oncology, Reproductive Medicine and Molecular Biology. According to data from OpenAlex, Michelle McMullen has authored 16 papers receiving a total of 674 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Reproductive Medicine and 3 papers in Molecular Biology. Recurrent topics in Michelle McMullen's work include Ovarian cancer diagnosis and treatment (7 papers), PARP inhibition in cancer therapy (7 papers) and COVID-19 and healthcare impacts (2 papers). Michelle McMullen is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), PARP inhibition in cancer therapy (7 papers) and COVID-19 and healthcare impacts (2 papers). Michelle McMullen collaborates with scholars based in Canada, Australia and United Kingdom. Michelle McMullen's co-authors include R.N. Colvile, Mark Nieuwenhuijsen, Ainhoa Madariaga, Amit M. Oza, Katherine Karakasis, Stéphanie Lheureux, Robert Rottapel, Georgia Halkett, Anna K. Nowak and Scott N. Taylor and has published in prestigious journals such as Journal of Clinical Oncology, The Science of The Total Environment and Clinical Cancer Research.

In The Last Decade

Michelle McMullen

12 papers receiving 653 citations

Peers

Michelle McMullen
Ruth Bell United Kingdom
Sofie De Prins Belgium
Jeffrey P. Baliff United States
JP Schouten Netherlands
Luise Cederkvist Denmark
Sherry Zhang United States
Ki‐Uk Kim South Korea
Frank D. Gilliland United States
Siu Wah Pang China
Ruth Bell United Kingdom
Michelle McMullen
Citations per year, relative to Michelle McMullen Michelle McMullen (= 1×) peers Ruth Bell

Countries citing papers authored by Michelle McMullen

Since Specialization
Citations

This map shows the geographic impact of Michelle McMullen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle McMullen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle McMullen more than expected).

Fields of papers citing papers by Michelle McMullen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle McMullen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle McMullen. The network helps show where Michelle McMullen may publish in the future.

Co-authorship network of co-authors of Michelle McMullen

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle McMullen. A scholar is included among the top collaborators of Michelle McMullen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle McMullen. Michelle McMullen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Collier, Elaine, Michelle McMullen, Jinfeng Zou, et al.. (2025). Circulating human papillomavirus DNA sequencing as a biomarker of response in advanced cervical cancer. International Journal of Gynecological Cancer. 35(6). 101755–101755.
2.
Fantoni, A, Tarek Meniawy, Paul A. Cohen, & Michelle McMullen. (2023). The impact of an educational and information systems initiative on somatic BRCA testing rates in patients with high grade serous tubo-ovarian cancer in Western Australia. Gynecologic Oncology Reports. 48. 101246–101246.
3.
Lheureux, Stéphanie, Michelle McMullen, Jennifer J. Knox, et al.. (2022). OZM-114: Phase Ib expansion study of CX-5461in patients with solid tumors and BRCA2 and/or PALB2 mutation.. Journal of Clinical Oncology. 40(16_suppl). TPS5621–TPS5621. 2 indexed citations
4.
Cook, Alistair, Alison M. McDonnell, Michael Millward, et al.. (2021). A phase 1b clinical trial optimizing regulatory T cell depletion in combination with platinum-based chemotherapy in thoracic cancers. Expert Review of Anticancer Therapy. 21(5). 465–474.
5.
Madariaga, Ainhoa, Qin Liu, Luisa Bonilla, et al.. (2021). Ethical frameworks in clinical research processes during COVID-19: a scoping review. BMJ Open. 11(7). e047076–e047076. 6 indexed citations
6.
Madariaga, Ainhoa, Gita Bhat, Michelle Wilson, et al.. (2021). Research biopsies in patients with gynecologic cancers: patient-reported outcomes, perceptions, and preferences. American Journal of Obstetrics and Gynecology. 225(6). 658.e1–658.e9. 5 indexed citations
7.
McMullen, Michelle, Katherine Karakasis, Robert Rottapel, & Amit M. Oza. (2021). Advances in ovarian cancer, from biology to treatment. Nature Cancer. 2(1). 6–8. 45 indexed citations
8.
9.
Madariaga, Ainhoa, Luisa Bonilla, Michelle McMullen, Amit M. Oza, & Stéphanie Lheureux. (2020). Efficacy and safety updates of poly ADP-ribose polymerase (PARP) inhibitor maintenance in ovarian cancer from ASCO 2020. International Journal of Gynecological Cancer. 30(8). 1256–1257. 2 indexed citations
10.
McMullen, Michelle, Ainhoa Madariaga, & Stéphanie Lheureux. (2020). New approaches for targeting platinum-resistant ovarian cancer. Seminars in Cancer Biology. 77. 167–181. 57 indexed citations
11.
12.
13.
McMullen, Michelle, Katherine Karakasis, Ainhoa Madariaga, & Amit M. Oza. (2020). Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer. Cancers. 12(6). 1607–1607. 114 indexed citations
14.
Madariaga, Ainhoa, Michelle McMullen, Rajat Kumar, et al.. (2020). COVID-19 Testing in Patients with Cancer: Does One Size Fit All?. Clinical Cancer Research. 26(18). 4737–4742. 20 indexed citations
15.
McMullen, Michelle, Peter K. H. Lau, Scott N. Taylor, et al.. (2017). Factors associated with psychological distress amongst outpatient chemotherapy patients: An analysis of depression, anxiety and stress using the DASS-21. Applied Nursing Research. 40. 45–50. 32 indexed citations
16.
Nieuwenhuijsen, Mark, et al.. (2001). Fine particle (PM2.5) personal exposure levels in transport microenvironments, London, UK. The Science of The Total Environment. 279(1-3). 29–44. 355 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruth Bell Breakdown of academic impact, for papers by Sofie De Prins Breakdown of academic impact, for papers by Jeffrey P. Baliff Breakdown of academic impact, for papers by JP Schouten Breakdown of academic impact, for papers by Luise Cederkvist Breakdown of academic impact, for papers by Sherry Zhang Breakdown of academic impact, for papers by Ki‐Uk Kim Breakdown of academic impact, for papers by Frank D. Gilliland Breakdown of academic impact, for papers by Siu Wah Pang
Rankless by CCL
2026